Correlation Between G1 Therapeutics and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both G1 Therapeutics and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining G1 Therapeutics and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between G1 Therapeutics and Caribou Biosciences, you can compare the effects of market volatilities on G1 Therapeutics and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in G1 Therapeutics with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of G1 Therapeutics and Caribou Biosciences.
Diversification Opportunities for G1 Therapeutics and Caribou Biosciences
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GTHX and Caribou is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding G1 Therapeutics and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and G1 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on G1 Therapeutics are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of G1 Therapeutics i.e., G1 Therapeutics and Caribou Biosciences go up and down completely randomly.
Pair Corralation between G1 Therapeutics and Caribou Biosciences
If you would invest 715.00 in G1 Therapeutics on September 19, 2024 and sell it today you would earn a total of 0.00 from holding G1 Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 4.55% |
Values | Daily Returns |
G1 Therapeutics vs. Caribou Biosciences
Performance |
Timeline |
G1 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Caribou Biosciences |
G1 Therapeutics and Caribou Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with G1 Therapeutics and Caribou Biosciences
The main advantage of trading using opposite G1 Therapeutics and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if G1 Therapeutics position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.G1 Therapeutics vs. Allogene Therapeutics | G1 Therapeutics vs. Heron Therapeuti | G1 Therapeutics vs. Annexon | G1 Therapeutics vs. Sangamo Therapeutics |
Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
CEOs Directory Screen CEOs from public companies around the world | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |